RxDoctor Payments Data

Chloe Lebron

Nurse Practitioner · Saint Paul, MNNPI 1881975712

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (58.9%), food and beverage and education — rather than concentrated in one kind of arrangement. Medtronic accounts for 65.2% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2023 at $3,432 and has fallen 89.7% since, to $352 in 2025. Among nurse practitioner clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,723in general payments, 2019–2025

Across 61 payments — averaging $110.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$4K
  • Boston Scientific$2K
  • Abbott$167
  • Abiomed$149
  • Biosense Webster, Inc.$115
  • W. L. Gore & Associates, Inc.$112
  • plus $136 from 3 others

What the payments were for

  • Travel & lodging$3,95859%
  • Food & beverage$2,70440%
  • Education$601%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,723 in reported general payments places this provider in the 95th percentile of 3,021 nurse practitioner providers in Minnesota.

See all nurse practitioner providers in Minnesota

Medicare billing

Part B allowed, 2024
$45,560
Medicare patients
239
Services billed
730

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban859$1,053,125
XareltoRivaroxaban126$153,983
Metoprolol Succinate536$11,048
SotalolSotalol Hcl424$10,587
Flecainide Acetate156$8,484
Amiodarone Hcl153$3,374
Diltiazem 24hr Er (Cd)Diltiazem Hcl60$2,254
Diltiazem 24hr Er (Xr)Diltiazem Hcl28$1,372
Metoprolol Tartrate120$1,268
Losartan Potassium65$870
Bumetanide15$794
Furosemide83$598
Lisinopril54$592
Pantoprazole Sodium70$565
Dilt-XrDiltiazem Hcl13$531

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Saint Paul

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →